UCB announced that it met the U.S. Food and Drug Administration (FDA) and clarified the requirements for the approval of the Biologics License Application (BLA) for Cimzia®, the first PEGylated anti-TNF, for the treatment of rheumatoid arthritis (RA). During the meeting, the FDA communicated that they require further analysis of existing data and a new [...]
Posts on ‘February 6th, 2009’
Arthritis exercise offered to East Hanover residents (Hanover Eagle)
EAST HANOVER TWP. -The Health Department and the Roseland Board of Health, along with the North Jersey Chapter of the arthritis Foundation, will offer the arthritis Foundation Exercise Program to East Hanover and Roseland residents from 8 a.m. to noon on Wednesdays beginning March 18 and continuing for eight weeks at the Tom Rinaldi Recreation [...]
Sign up for South Shore Arthritis Walk (Kingston Reporter)
This year’s adult ambassador for the South Shore arthritis Walk, Rita Johnson, invites all to sign up for the charity walk, which will be held from 10 a.m. to 2 p.m. Sunday, May 17, at Nelson Park in Plymouth.
Process Found To Play Role In Rheumatoid Arthritis Could Lead To New Treatment (Science Daily)
Although the origin of rheumatoid arthritis remains unclear, bioactive proteins known as cytokines, particularly TNF± and IL-6, which are involved in inflammation, play a major role in the disease by contributing to joint and tissue destruction.
